Evidence map›Paper›PMID 36172156›Full record

ArticleFrontiers in oncology2022

Sacral Ewing sarcoma with rib, lung, and multifocal skull metastases: A rare case report and review of treatments.

Chen Ye, Wei Wei, Xuebin Tang, Feng Li, Baoquan Xin, Qianqian Chen, Haifeng Wei, Shaohui He, Jianru Xiao

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Chen YeSchool of Health Science and Technology, University of Shanghai for Science and Technology, Shanghai, China.
Wei WeiSchool of Health Science and Technology, University of Shanghai for Science and Technology, Shanghai, China.
Xuebin TangDepartment of Orthopaedics, The Second Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Feng LiDepartment of Orthopaedics, the 943rd Hospital of Joint Logistics Support Force of People's Liberation Army, Wuwei, China.
Baoquan XinSchool of Health Science and Technology, University of Shanghai for Science and Technology, Shanghai, China.
Qianqian ChenSchool of Health Science and Technology, University of Shanghai for Science and Technology, Shanghai, China.
Haifeng WeiSchool of Health Science and Technology, University of Shanghai for Science and Technology, Shanghai, China.
Shaohui HeSpinal Tumor Center, Department of Orthopaedic Oncology, Changzheng Hospital, Second Military Medical University, Shanghai, China.
Jianru XiaoSchool of Health Science and Technology, University of Shanghai for Science and Technology, Shanghai, China.
Second Military Medical University · CNUniversity of Shanghai for Science and Technology · CNXuzhou Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ewing sarcoma (ES) rarely derives from the sacrum or mobile spine. The discovery of primary ES with multimetastatic involvements is exceedingly less frequent in clinical practice. A 23-year-old man with initial primary sacral ES developed metastases of rib, lung, and multifocal skull after receiving surgical intervention and series of adjuvant therapies. We provide this very rare case consisting of its clinical features, imaging findings, treatments, and outcomes. Therapeutic modalities of ES are also reviewed in previous published articles. The prognosis of metastatic ES remains dismal; effective therapeutic modalities for ES require multidisciplinary collaboration, with more high-quality clinical trials to promote the optimal protocols.

Indexed as

decision optimizationen bloc resectionewing sarcomamultidisciplinary treatmentsmultifocal metastases

Identifiers

PMID36172156
PMCPMC9511402
OpenAlexW4294739130

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.